Samlyn Capital, LLC Merus N.V. Transaction History
Samlyn Capital, LLC
- $6.21 Billion
- Q4 2024
A detailed history of Samlyn Capital, LLC transactions in Merus N.V. stock. As of the latest transaction made, Samlyn Capital, LLC holds 2,668,178 shares of MRUS stock, worth $115 Million. This represents 1.81% of its overall portfolio holdings.
Number of Shares
2,668,178
Previous 2,610,393
2.21%
Holding current value
$115 Million
Previous $130 Million
13.97%
% of portfolio
1.81%
Previous 2.1%
Shares
10 transactions
Others Institutions Holding MRUS
# of Institutions
202Shares Held
57.2MCall Options Held
111KPut Options Held
85.7K-
Rtw Investments, LP New York, NY4.17MShares$180 Million2.86% of portfolio
-
Commodore Capital LP New York, NY3.87MShares$167 Million16.32% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.97MShares$129 Million3.1% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.13MShares$91.9 Million1.3% of portfolio
-
Franklin Resources Inc San Mateo, CA1.98MShares$85.8 Million0.02% of portfolio
About Merus N.V.
- Ticker MRUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,878,200
- Market Cap $1.98B
- Description
- Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...